Artificial Intelligence In Drug Discovery Market Size, Share & Trends Report

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Space (Oncology, Neurodegenerative Diseases), By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68039-029-7
  • Number of Report Pages: 80
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Artificial Intelligence (AI) in Drug Discovery Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Drug optimization and repurposing
    • Preclinical testing
    • Others
  • Artificial Intelligence (AI) in Drug Discovery Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
    • Neurodegenerative Diseases
    • Cardiovascular Disease
    • Metabolic Diseases
    • Infectious Disease
    • Others
  • Artificial Intelligence (AI) in Drug Discovery Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America AI in Drug Discovery Application Outlook
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • North America AI in Drug Discovery Therapeutic Space
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • U.S.
        • U.S. AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • U.S. AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Canada
        • Canada AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Canada AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Mexico
        • Mexico AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Mexico AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
    • Europe
      • Europe AI in Drug Discovery Application Outlook
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • Europe AI in Drug Discovery Therapeutic Space
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • UK
        • UK AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • UK AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Germany
        • Germany AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Germany AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • France
        • France AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • France AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Italy
        • Italy AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Italy AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Spain
        • Spain AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Spain AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Denmark
        • Denmark AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Denmark AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Sweden
        • Sweden AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Sweden AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Norway
        • Norway AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Norway AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
    • Asia Pacific
      • Asia Pacific AI in Drug Discovery Application Outlook
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • Asia Pacific AI in Drug Discovery Therapeutic Space
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • Japan
        • Japan AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Japan AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • China
        • China AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • China AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • India
        • India AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • India AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • South Korea
        • South Korea AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • South Korea AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Australia
        • Australia AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Australia AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
    • Latin America
      • Latin America AI in Drug Discovery Application Outlook
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • Latin America AI in Drug Discovery Therapeutic Space
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • Brazil
        • Brazil AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Brazil AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Argentina
        • Argentina AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Argentina AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
    • MEA
      • MEA AI in Drug Discovery Application Outlook
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • MEA AI in Drug Discovery Therapeutic Space
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • South Africa
        • South Africa AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • South Africa AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Saudi Arabia
        • Saudi Arabia AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Saudi Arabia AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • UAE
        • UAE AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • UAE AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
      • Kuwait
        • Kuwait AI in Drug Discovery Application Outlook
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Kuwait AI in Drug Discovery Therapeutic Space
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon